Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis ...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Related: Costco's 'Sparkling' and 'Tangy' Summery Treat Has Fan's Racing to Stores: 'Need to Find These ASAP' ...

ESA astronaut Samantha Cristoforetti delivered video - Technique shows how to dispose trash on the International Space ...

Source: Malaria cases in Mash West increase – herald Conrad Mupesa-Mashonaland West Bureau MASHONALAND West Province is ...

The publication reports results from the 96-week SYMMETRY study evaluating the efficacy and safety of Akero's lead FGF21 ...

These include a series of bottled-in-bond vintage releases, and the details of the latest one were just announced.

“It is an absolute phenom for us to be able to present to you now our teenage aspirations in this song”: Joe Satriani and ...

Doom: The Dark Ages is a slay. Its intense battles and awe-inspiring scale outweighs its inconsistent parts by a high ...